UK MHRA approves clinical trial of JHL biosimilar to treat RA

The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a Phase I clinical trial of JHL1101, a potential treatment for rheumatoid arthritis (RA).
Source: Drug Development Technology - Category: Pharmaceuticals Source Type: news